Connect with us

News

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Digital Finance News Staff

Published

on

Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Ceapro Inc.

Ceapro Inc.

– Q1 2024 marked by significant advancement of R&D projects focused on avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the building of pilot scale units for PGX Technology

– Q1 2024 sales of $2,800,000 vs $3,500,000 in Q1 2023

– Announced approval by shareholders of merger of equals with Aeterna Zentaris to create a diversified biopharmaceutical company; expected to close in the second quarter of 2024, subject to the closing conditions

EDMONTON, Alberta, May 29, 2024 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the first quarter ended March 31, 2024.

“We are excited by the advancement of several key milestones related to new product and technology development. We are making progress on multiple fronts including the team at Montreal Heart Institute completing the first arm of the Phase 1 clinical study with avenanthramides and the team at Ceapro working to complete the scale-up of the PGX Technology at the Edmonton facility using fully defined yeast beta glucan. With the return of the re-ordering pattern from one major customer and the expected shared benefits that should result from the upcoming merger of equals with Aeterna Zentaris, we believe we are poised to significantly propel the Company into its next phase of growth and unlock value as a diversified biopharmaceutical company,” stated Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro.

Corporate and Operational Highlights

Pipeline Development

Focus maintained on the development of avenanthramides and the scale-up of the PGX Technology

Avenanthramides:

Clinical

Story continues

Formulation, Stability Studies and Analytics

Yeast Beta Glucan (YBG)

Specifications have been standardized and the product is being used for the PGX scale-up projects in Edmonton and Austria.

Technology:

Pressurized Gas eXpanded Technology (PGX):

  • Edmonton Main Facility – PGX Scale-Up 50 Liters Vessel: Construction and installation were completed during Q1 2024. Several trial runs of yeast beta glucan have been performed as part of the last commissioning “fine tuning” phase. Given that the Edmonton site license is for natural products, yeast beta glucan produced from this facility will be offered as a nutraceutical. Subject to approval by Health Canada, this product could be launched by end of 2024.

Corporate:

  • Received on March 28, 2024 the final court approval for merger with AeternaZentaris to create a diversified biopharmaceutical company; expected to close in the second quarter of 2024; subject to the closing conditions.

Financial Highlights for the First Quarter Ended March 31, 2024

  • Total sales of $2,800,000 for the first quarter of 2024 compared to $3,500,000 for the comparative quarter in 2023. The decrease compared to last year was primarily due to a significant decrease in product sales of oat oil. One major customer is gradually resuming ordering pattern with flagship product, avenanthramides.

  • Net loss of $1,900,000 in Q1 2024 compared to a net loss of $385,000 in Q1 2023. Loss was incurred due to lower sales, increased R&D investments as well as non-recurrent increased G&A expenses mostly due to professional fees incurred for the expected merger with Aeterna Zentaris.

  • Positive working capital balance of $10,219,022 as of March 31, 2024.

“As we expect renewed growth with our active ingredients revenue generating base business and subject to the closing and successful integration of the merger with Aeterna Zentaris, the Company expects to complete prioritized projects using cash on hand while continuing to assess different market initiatives to bring new business and unlock value,” concluded Mr. Gagnon.

 

CEAPRO INC.

Condensed Interim Consolidated Balance Sheets

Unaudited

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

 

 

2024

 

2023

 

 

 

$

 

$

 

ASSETS

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash

 

4,746,901

 

8,843,742

 

Trade receivables

 

1,677,934

 

167,295

 

Other receivables

 

204,911

 

216,763

 

Inventories (note 3)

 

4,778,701

 

5,308,987

 

Prepaid expenses and deposits

 

485,826

 

310,191

 

Total Current Assets

 

11,894,273

 

14,846,978

 

Non-Current Assets

 

 

 

 

 

Restricted cash

 

10,000

 

10,000

 

Investment tax credits receivable

 

984,200

 

984,200

 

Deposits

 

74,369

 

74,369

 

Licences (note 4)

 

8,884

 

9,625

 

Property and equipment (note 5)

 

15,783,093

 

15,421,884

 

Deferred tax assets

 

654,850

 

98,778

 

Total Non-Current Assets

 

17,515,396

 

16,598,856

 

TOTAL ASSETS

 

29,409,669

 

31,445,834

 

LIABILITIES AND EQUITY

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Accounts payable and accrued liabilities

 

1,273,963

 

1,342,156

 

Current portion of lease liabilities (note 6)

 

401,288

 

396,232

 

Total Current Liabilities

 

1,675,251

 

1,738,388

 

Non-Current Liabilities

 

 

 

 

 

Long-term lease liabilities (note 6)

 

1,750,106

 

1,852,345

 

Total Non-Current Liabilities

 

1,750,106

 

1,852,345

 

TOTAL LIABILITIES

 

3,425,357

 

3,590,733

 

Equity

 

 

 

 

 

Share capital (note 7 (b))

 

16,721,867

 

16,721,867

 

Contributed surplus

 

4,982,466

 

4,963,067

 

Retained earnings

 

4,279,979

 

6,170,167

 

Total Equity

 

25,984,312

 

27,855,101

 

TOTAL LIABILITIES AND EQUITY

 

29,409,669

 

31,445,834

 

CEAPRO INC.

Condensed Interim Consolidated Statements of Net Loss and Comprehensive Loss

Unaudited

 

 

 

 

 

 

2024

 

2023

 

Three Months Ended March 31,

 

$

 

$

 

Revenue (note 13)

 

2,773,788

 

3,494,811

 

Cost of goods sold

 

1,555,382

 

1,888,973

 

Gross margin

 

1,218,406

 

1,605,838

 

Research and product development

 

1,432,824

 

573,687

 

General and administration

 

2,229,528

 

1,521,445

 

Sales and marketing

 

4,559

 

8,179

 

Finance costs (note 9)

 

84,419

 

88,800

 

Loss from operations

 

(2,532,924

)

(586,273

)

Other income (note 10)

 

(86,664

)

(95,875

)

Loss before income taxes

 

(2,446,260

)

(490,398

)

Deferred tax benefit

 

(556,072

)

(105,348

)

Net loss and comprehensive loss for the period

 

(1,890,188

)

(385,050

)

Net loss per common share (note 16):

 

 

 

Basic

 

(0.02

)

(0.00

)

Diluted

 

(0.02

)

(0.00

)

Weighted average number of common shares outstanding (note 16):

 

 

 

Basic

 

78,293,177

 

78,251,844

 

Diluted

 

78,293,177

 

78,251,844

 

CEAPRO INC.

Condensed Interim Consolidated Statements of Cash Flows

Unaudited

 

 

 

 

 

 

2024

 

2023

 

Three Months Ended March 31,

 

$

 

$

 

OPERATING ACTIVITIES

 

 

 

Net loss for the period

 

(1,890,188

)

(385,050

)

Adjustments for items not involving cash

 

 

 

Finance costs

 

29,419

 

33,800

 

Depreciation and amortization

 

484,351

 

485,253

 

Deferred income tax benefit

 

(556,072

)

(105,348

)

Share-based payments

 

19,399

 

134,083

 

 

 

(1,913,091

)

162,738

 

CHANGES IN NON-CASH WORKING CAPITAL ITEMS

 

 

 

Trade receivables

 

(1,510,639

)

(90,938

)

Other receivables

 

11,852

 

10,389

 

Inventories

 

530,286

 

(488,465

)

Prepaid expenses and deposits

 

(161,825

)

(34,397

)

Accounts payable and accrued liabilities relating to operating activities

 

(165,513

)

(646,806

)

 

 

(1,295,839

)

(1,250,217

)

Net loss for the period adjusted for non-cash and working capital items

 

(3,208,930

)

(1,087,479

)

Interest paid

 

(29,419

)

(33,800

)

CASH USED IN OPERATIONS

 

(3,238,349

)

(1,121,279

)

INVESTING ACTIVITIES

 

 

 

Purchase of property and equipment

 

(747,499

)

(24,643

)

Deposits relating to the purchase of equipment

 

(13,810

)

(17,419

)

CASH USED IN INVESTING ACTIVITIES

 

(761,309

)

(42,062

)

FINANCING ACTIVITIES

 

 

 

Stock options exercised

 

 

2,000

 

Repayment of lease liabilities

 

(97,183

)

(86,188

)

CASH USED IN FINANCING ACTIVITIES

 

(97,183

)

(84,188

)

Decrease in cash

 

(4,096,841

)

(1,247,529

)

Cash at beginning of the period

 

8,843,742

 

13,810,998

 

Cash at end of the period

 

4,746,901

 

12,563,469

 

 

 

 

 

The complete financial statements are available for review on SEDAR at https://sedar.com/Ceapro and on the Company’s website at www.ceapro.com.

About Ceapro Inc.

Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.

Forward-looking information

The information in this news release has been prepared as at May 29, 2024. Certain statements made herein, including statements relating to matters that are not historical facts and statements of the Company’s beliefs, intentions and expectations about developments, results and events which will or may occur in the future, constitute “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information relates to future events or future performance, reflect current expectations or beliefs regarding future events and is typically identified by words such as “aim”, “anticipate”, “assume”, “believe”, “continue”, “could”, “expect”, “forecast”, “future”, “intend”, “maintain”, “may”, “outlook”, “plan”, “potential”, “project”, “synergies”, “will”, and similar expressions suggesting future outcomes or statements regarding an outlook.

Forward-looking information is based upon certain assumptions and other important factors that, if untrue, could cause the actual results, performance or achievements of the Company or the combined company to be materially different from future results, performance or achievements expressed or implied by such information. There can be no assurance that such information will prove to be accurate. Such information being based on numerous assumptions.

Readers are cautioned not to place undue reliance on forward-looking information, which speak only as of the date made. For a more detailed discussion of such risks and other factors that may affect Ceapro’s ability to achieve the expectations set forth in the forward-looking information contained in this news release, see Ceapro’s management information circular dated February 9, 2024, MD&A filed under Ceapro’s profile on SEDAR+ at www.sedarplus.ca, as well as Ceapro’s other filings with the Canadian securities regulators. Other than as required by law, the Company does not intend, and does not assume any obligation to, update the forward-looking information in this news release.

For more information contact:

Issuer:
Gilles R. Gagnon, M.Sc., MBA
President & CEO
T: 780-421-4555

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Fuente

We are the editorial team of Digital Finance News, where seriousness meets clarity in cryptocurrency analysis. With a robust team of finance and blockchain technology experts, we are dedicated to meticulously exploring complex crypto markets with detailed assessments and an unbiased approach. Our mission is to democratize access to knowledge of emerging financial technologies, ensuring they are understandable and accessible to all. In every article on Digital Finance News, we strive to provide content that not only educates, but also empowers our readers, facilitating their integration into the financial digital age.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Información básica sobre protección de datos Ver más

  • Responsable: Miguel Mamador.
  • Finalidad:  Moderar los comentarios.
  • Legitimación:  Por consentimiento del interesado.
  • Destinatarios y encargados de tratamiento:  No se ceden o comunican datos a terceros para prestar este servicio. El Titular ha contratado los servicios de alojamiento web a Banahosting que actúa como encargado de tratamiento.
  • Derechos: Acceder, rectificar y suprimir los datos.
  • Información Adicional: Puede consultar la información detallada en la Política de Privacidad.

News

Modiv Industrial to release Q2 2024 financial results on August 6

Digital Finance News Staff

Published

on

Business Wire

RENO, Nev., August 1, 2024–(BUSINESS THREAD)–Modiv Industrial, Inc. (“Modiv” or the “Company”) (NYSE:MDV), the only public REIT focused exclusively on the acquisition of industrial real estate properties, today announced that it will release second quarter 2024 financial results for the quarter ended June 30, 2024 before the market opens on Tuesday, August 6, 2024. Management will host a conference call the same day at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time) to discuss the results.

Live conference call: 1-877-407-0789 or 1-201-689-8562 at 7:30 a.m. Pacific Time Tuesday, August 6.

Internet broadcast: To listen to the webcast, live or archived, use this link https://callme.viavid.com/viavid/?callme=true&passcode=13740174&h=true&info=company&r=true&B=6 or visit the investor relations page of the Modiv website at www.modiv.com.

About Modiv Industrial

Modiv Industrial, Inc. is an internally managed REIT focused on single-tenant net-leased industrial manufacturing real estate. The company actively acquires critical industrial manufacturing properties with long-term leases to tenants that fuel the national economy and strengthen the nation’s supply chains. For more information, visit: www.modiv.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240731628803/en/

Contacts

Investor Inquiries:
management@modiv.com

Fuente

Continue Reading

News

Volta Finance Limited – Director/PDMR Shareholding

Digital Finance News Staff

Published

on

Volta Finance Limited - Director/PDMR Shareholding

Volta Finance Limited

Volta Finance Limited

Volta Finance Limited (VTA/VTAS)

Notification of transactions by directors, persons exercising managerial functions
responsibilities and people closely associated with them

NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN THE UNITED STATES

*****
Guernsey, 1 August 2024

Pursuant to announcements made on 5 April 2019 and 26 June 2020 relating to changes to the payment of directors’ fees, Volta Finance Limited (the “Company” or “Volta”) purchased 3,380 no par value ordinary shares of the Company (“Ordinary Shares”) at an average price of €5.2 per share.

Each director receives 30% of his or her director’s fee for any year in the form of shares, which he or she is required to hold for a period of not less than one year from the respective date of issue.

The shares will be issued to the Directors, who for the purposes of Regulation (EU) No 596/2014 on Market Abuse (“March“) are “people who exercise managerial responsibilities” (a “PDMR“).

  • Dagmar Kershaw, Chairman and MDMR for purposes of MAR, has acquired an additional 1,040 Common Shares in the Company. Following the settlement of this transaction, Ms. Kershaw will have an interest in 12,838 Common Shares, representing 0.03% of the Company’s issued shares;

  • Stephen Le Page, a Director and a PDMR for MAR purposes, has acquired an additional 728 Ordinary Shares in the Company. Following the settlement of this transaction, Mr. Le Page will have an interest in 50,562 Ordinary Shares, representing 0.14% of the issued shares of the Company;

  • Yedau Ogoundele, Director and a PDMR for the purposes of MAR has acquired an additional 728 Ordinary Shares in the Company. Following the settlement of this transaction, Ms. Ogoundele will have an interest in 6,862 Ordinary Shares, representing 0.02% of the issued shares of the Company; and

  • Joanne Peacegood, Director and PDMR for MAR purposes has acquired an additional 884 Ordinary Shares in the Company. Following the settlement of this transaction, Ms. Peacegood will have an interest in 3,505 Ordinary Shares, representing 0.01% of the issued shares of the Company;

The notifications below, made in accordance with the requirements of the MAR, provide further details in relation to the above transactions:

a) Dagmar Kershaw
PRESIDENT AND DIRECTOR

b) Stephen LePage
DIRECTOR

c) Yedau Ogoundele
DIRECTOR

e) Joanne Pazgood
DIRECTOR

a. Position/status

Director

b. Initial Notification/Amendment

Initial notification

  • Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a name

Volta Finance Limited

b. LAW

2138004N6QDNAZ2V3W80

a. Description of the financial instrument, type of instrument

Ordinary actions

b. Identification code

GG00B1GHHH78

c. Nature of the transaction

Acquisition and Allocation of Common Shares in Relation to Partial Payment of Directors’ Fees for the Quarter Ended July 31, 2024

d. Price(s)

€5.2 per share

e. Volume(s)

Total: 3380

f. Transaction date

August 1, 2024

g. Location of transaction

At the Market – London

The)
Dagmar Kershaw
President and Director

B)
Steve LePage
Director

w)
Yedau Ogoundele Director

It is)
Joanne Pazgood
Director

Aggregate Volume:
1,040

Price:
€5.2 per share

Aggregate Volume:
728

Price:
€5.2 per share

Aggregate Volume:
728

Price:
€5.2 per share

Aggregate Volume:
884

Price:
€5.2 per share

CONTACTS

For the investment manager
AXA Investment Managers Paris
Francois Touati
francois.touati@axa-im.com
+33 (0) 1 44 45 80 22

Olivier Pons
Olivier.pons@axa-im.com
+33 (0) 1 44 45 87 30

Company Secretary and Administrator
BNP Paribas SA, Guernsey branch
guernsey.bp2s.volta.cosec@bnpparibas.com
+44 (0) 1481 750 853

Corporate Broker
Cavendish Securities plc
Andre Worn Out
Daniel Balabanoff
+44 (0) 20 7397 8900

*****
ABOUT VOLTA FINANCE LIMITED

Volta Finance Limited is incorporated in Guernsey under the Companies (Guernsey) Law, 2008 (as amended) and listed on Euronext Amsterdam and the Main Market of the London Stock Exchange for listed securities. Volta’s home member state for the purposes of the EU Transparency Directive is the Netherlands. As such, Volta is subject to the regulation and supervision of the AFM, which is the regulator of the financial markets in the Netherlands.

Volta’s investment objectives are to preserve its capital throughout the credit cycle and to provide a stable income stream to its shareholders through dividends that it expects to distribute quarterly. The company currently seeks to achieve its investment objectives by seeking exposure predominantly to CLOs and similar asset classes. A more diversified investment strategy in structured finance assets may be pursued opportunistically. The company has appointed AXA Investment Managers Paris, an investment management firm with a division specializing in structured credit, to manage the investment portfolio of all of its assets.

*****

ABOUT AXA INVESTMENT MANAGERS
AXA Investment Managers (AXA IM) is a multi-specialist asset management firm within the AXA Group, a global leader in financial protection and wealth management. AXA IM is one of the largest European-based asset managers with 2,700 professionals and €844 billion in assets under management at the end of December 2023.

*****

This press release is issued by AXA Investment Managers Paris (“AXA IM”) in its capacity as alternative investment fund manager (within the meaning of Directive 2011/61/EU, the “AIFM Directive”) of Volta Finance Limited (“Volta Finance”), the portfolio of which is managed by AXA IM.

This press release is for information only and does not constitute an invitation or inducement to purchase shares of Volta Finance. Its circulation may be prohibited in certain jurisdictions and no recipient may circulate copies of this document in violation of such limitations or restrictions. This document is not an offer to sell the securities referred to herein in the United States or to persons who are “U.S. persons” for purposes of Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or otherwise in circumstances where such an offering would be restricted by applicable law. Such securities may not be sold in the United States absent registration or an exemption from registration under the Securities Act. Volta Finance does not intend to register any part of the offering of such securities in the United States or to conduct a public offering of such securities in the United States.

*****

This communication is being distributed to, and is directed only at, (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth companies and other persons to whom it may lawfully be communicated falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The securities referred to herein are available only to, and any invitation, offer or agreement to subscribe for, purchase or otherwise acquire such securities will be made only to, relevant persons. Any person who is not a relevant person should not act on or rely on this document or any of its contents. Past performance should not be relied upon as a guide to future performance.

*****
This press release contains statements that are, or may be deemed to be, “forward-looking statements”. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes”, “anticipates”, “expects”, “intends”, “is/are expected”, “may”, “will” or “should”. They include statements about the level of the dividend, the current market environment and its impact on the long-term return on Volta Finance’s investments. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that such forward-looking statements are not guarantees of future performance. Actual results, portfolio composition and performance of Volta Finance may differ materially from the impression created by the forward-looking statements. AXA IM undertakes no obligation to publicly update or revise forward-looking statements.

Any target information is based on certain assumptions as to future events that may not materialize. Due to the uncertainty surrounding these future events, targets are not intended to be and should not be considered to be profits or earnings or any other type of forecast. There can be no assurance that any of these targets will be achieved. Furthermore, no assurance can be given that the investment objective will be achieved.

Figures provided which relate to past months or years and past performance cannot be considered as a guide to future performance or construed as a reliable indicator as to future performance. Throughout this review, the citation of specific trades or strategies is intended to illustrate some of Volta Finance’s investment methodologies and philosophies as implemented by AXA IM. The historical success or AXA IM’s belief in the future success of any such trade or strategy is not indicative of, and has no bearing on, future results.

The valuation of financial assets may vary significantly from the prices that AXA IM could obtain if it sought to liquidate the positions on Volta Finance’s behalf due to market conditions and the general economic environment. Such valuations do not constitute a fairness or similar opinion and should not be relied upon as such.

Publisher: AXA INVESTMENT MANAGERS PARIS, a company incorporated under the laws of France, with registered office at Tour Majunga, 6, Place de la Pyramide – 92800 Puteaux. AXA IMP is authorized by Autorité des Marchés Financiers under registration number GP92008 as an alternative investment fund manager within the meaning of the AIFM Directive.

*****

Fuente

Continue Reading

News

Apple to report third-quarter earnings as Wall Street eyes China sales

Digital Finance News Staff

Published

on

Apple to report third-quarter earnings as Wall Street eyes China sales

Litter (AAPL) is set to report its fiscal third-quarter earnings after the market closes on Thursday, and unlike the rest of its tech peers, the main story won’t be about the rise of AI.

Instead, analysts and investors will be keeping a close eye on iPhone sales in China and whether Apple has managed to stem the tide of users switching to domestic rivals including Huawei.

For the quarter, analysts expect Apple to report earnings per share (EPS) of $1.35 on revenue of $84.4 billion, according to estimates compiled by Bloomberg. Apple saw EPS of $1.26 on revenue of $81.7 billion in the same period last year.

Apple shares are up about 18.6% year to date despite a rocky start to the year, thanks in part to the impact of the company’s Worldwide Developer Conference (WWDC) in May, where showed off its Apple Intelligence software.

But the big question on investors’ minds is whether iPhone sales have risen or fallen in China. Apple has struggled with slowing phone sales in the region, with the company noting an 8% decline in sales in the second quarter as local rivals including Huawei and Xiaomi gain market share.

CUPERTINO, CALIFORNIA - JUNE 10: Apple CEO Tim Cook delivers remarks at the start of the Apple Worldwide Developers Conference (WWDC) on June 10, 2024 in Cupertino, California. Apple will announce plans to incorporate artificial intelligence (AI) into Apple software and hardware. (Photo by Justin Sullivan/Getty Images)

Apple CEO Tim Cook delivers remarks at the start of the Apple Worldwide Developers Conference (WWDC). (Photo by Justin Sullivan/Getty Images) (Justin Sullivan via Getty Images)

And while some analysts, such as JPMorgan’s Samik Chatterjee, believe sales in Greater China, which includes mainland China, Hong Kong, Singapore and Taiwan, rose in the third quarter, others, including David Vogt of UBS Global Research, say sales likely fell about 6%.

Analysts surveyed by Bloomberg say Apple will report revenue of $15.2 billion in Greater China, down 3.1% from the same quarter last year, when Apple reported revenue of $15.7 billion in China. Overall iPhone sales are expected to reach $38.9 billion, down 1.8% year over year from the $39.6 billion Apple saw in the third quarter of 2023.

But Apple is expected to make up for those declines in other areas, including Services and iPad sales. Services revenue is expected to reach $23.9 billion in the quarter, up from $21.2 billion in the third quarter of 2023, while iPad sales are expected to reach $6.6 billion, up from the $5.7 billion the segment brought in in the same period last year. Those iPad sales projections come after Apple launched its latest iPad models this year, including a new iPad Pro lineup powered by the company’s M4 chip.

Mac revenue is also expected to grow modestly in the quarter, versus a 7.3% decline last year. Sales of wearables, which include the Apple Watch and AirPods, however, are expected to decline 5.9% year over year.

In addition to Apple’s revenue numbers, analysts and investors will be listening closely for any commentary on the company’s software launches. Apple Intelligence beta for developers earlier this week.

The story continues

The software, which is powered by Apple’s generative AI technology, is expected to arrive on iPhones, iPads and Macs later this fall, though according to Bloomberg’s Marc GurmanIt won’t arrive alongside the new iPhone in September. Instead, it’s expected to arrive on Apple devices sometime in October.

Analysts are divided on the potential impact of Apple Intelligence on iPhone sales next year, with some saying the software will kick off a new iPhone sales supercycle and others offering more pessimistic expectations about the technology’s effect on Apple’s profits.

It’s important to note that Apple Intelligence is only compatible with the iPhone 15 Pro and newer phones, ensuring that all users desperate to get their hands on the tech will have to upgrade to a newer, more powerful phone as soon as it is available.

Either way, if Apple wants to make Apple Intelligence a success, it will need to ensure it has the features that will make customers excited to take advantage of the offering.

Subscribe to the Yahoo Finance Tech newsletter.Subscribe to the Yahoo Finance Tech newsletter.

Subscribe to the Yahoo Finance Tech Newsletter. (Yahoo Finance)

Email Daniel Howley at dhowley@yahoofinance.com. Follow him on Twitter at @DanielHowley.

For the latest earnings reports and analysis, earnings rumors and expectations, and company earnings news, click here

Read the latest financial and business news from Yahoo Finance



Fuente

Continue Reading

News

Number of Americans filing for unemployment benefits hits highest level in a year

Digital Finance News Staff

Published

on

Number of Americans filing for unemployment benefits hits highest level in a year

The number of Americans filing for unemployment benefits hit its highest level in a year last week, even as the job market remains surprisingly healthy in an era of high interest rates.

Jobless claims for the week ending July 27 rose 14,000 to 249,000 from 235,000 the previous week, the Labor Department said Thursday. It’s the highest number since the first week of August last year and the 10th straight week that claims have been above 220,000. Before that period, claims had remained below that level in all but three weeks this year.

Weekly jobless claims are widely considered representative of layoffs, and while they have been slightly higher in recent months, they remain at historically healthy levels.

Strong consumer demand and a resilient labor market helped avert a recession that many economists predicted during the Federal Reserve’s prolonged wave of rate hikes that began in March 2022.

As inflation continues to declinethe Fed’s goal of a soft landing — reducing inflation without causing a recession and mass layoffs — appears to be within reach.

On Wednesday, the Fed left your reference rate aloneBut officials have strongly suggested a cut could come in September if the data stays on its recent trajectory. And recent labor market data suggests some weakening.

The unemployment rate rose to 4.1% in June, despite the fact that American employers added 206,000 jobs. U.S. job openings also fell slightly last month. Add that to the rise in layoffs, and the Fed could be poised to cut interest rates next month, as most analysts expect.

The four-week average of claims, which smooths out some of the weekly ups and downs, rose by 2,500 to 238,000.

The total number of Americans receiving unemployment benefits in the week of July 20 jumped by 33,000 to 1.88 million. The four-week average for continuing claims rose to 1,857,000, the highest since December 2021.

Continuing claims have been rising in recent months, suggesting that some Americans receiving unemployment benefits are finding it harder to get jobs.

There have been job cuts across a range of sectors this year, from agricultural manufacturing Deerefor media such as CNNIt is in another place.

Fuente

Continue Reading

Trending

Copyright © 2024 DIGITALFINANCENEWS.LIFE All rights reserved. This website provides educational content and highlights that investing involves risks. It is essential to conduct thorough research before investing and to be prepared to assume potential losses. Be sure to fully understand the risks involved before making investment decisions. Important: We do not provide financial or investment advice. All content is presented for educational purposes only.